Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WNK1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | COL17A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | SNRPB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | PSMB6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | B3GNT3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | FAM65A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | SENP3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | EID2B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | PROX1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | CNTD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |